Proteases: Biological Roles, Classification & Disease Implications

Proteases (also called peptidases or proteinases) are enzymes that catalyze the hydrolysis of peptide bonds in proteins and peptides. Proteolysis—the cleavage of proteins—is a fundamental biological process essential for life, regulating protein activation, degradation, signaling, and turnover.

Classification by Catalytic Mechanism

Proteases are grouped by the nucleophilic amino acid (or water molecule) at their active site:

• Serine proteases: Use a catalytic serine residue (often in a catalytic triad: Ser-His-Asp). Examples: trypsin, chymotrypsin, elastase, thrombin, plasmin, tissue plasminogen activator (tPA), granzymes, complement factors.
• Cysteine proteases: Use a catalytic cysteine (often Cys-His dyad). Examples: papain, bromelain, caspases (apoptosis), cathepsins B/L/K/S, calpains, cruzain (T. cruzi).
• Aspartic proteases: Use two aspartic acid residues to activate a water molecule. Examples: pepsin, cathepsin D, renin, HIV-1 protease, BACE1 (Alzheimer's target).
• Metalloproteases: Use a metal ion (usually Zn²⁺) to activate water. Examples: matrix metalloproteinases (MMPs), ADAMs, neprilysin, angiotensin-converting enzyme (ACE), thermolysin.
• Threonine proteases: Use an N-terminal threonine. Example: proteasome β-subunits.
• Glutamic acid proteases: Rare; use glutamic acid. Example: eqolisin.

They are also classified by substrate specificity (exopeptidases vs. endopeptidases; highly specific vs. promiscuous) and evolutionary clans (MEROPS database).

Biological Functions

• Digestion: Pancreatic proteases (trypsin, chymotrypsin, carboxypeptidases) and gastric pepsin break dietary proteins into absorbable peptides/amino acids.
• Blood coagulation & fibrinolysis: Thrombin, factors VIIa, IXa, Xa, XIa, XIIa (coagulation); plasmin, tPA (fibrinolysis). Tightly regulated cascades.
• Hormone & growth factor processing: Cleavage of prohormones to active hormones (insulin from proinsulin, angiotensin II from angiotensin I via ACE, PTH, glucagon).
• Apoptosis (programmed cell death): Caspases (cysteine-aspartic proteases) dismantle cellular structures in orderly fashion.
• Protein quality control & turnover: Proteasome (ubiquitin-proteasome system), lysosomal cathepsins, mitochondrial proteases degrade misfolded/damaged/regulatory proteins.
• Immune defense: Granzymes (cytotoxic T/NK cells), neutrophil elastase, complement, antimicrobial peptides.
• Cell signaling & development: Notch cleavage (γ-secretase), Wnt processing, growth factor shedding (ADAMs), PAR activation by thrombin.

Disease Implications & Therapeutic Targeting

• Excessive protease activity: Tissue destruction in emphysema (elastase > α1-antitrypsin), arthritis (MMPs, aggrecanases), cancer metastasis (MMPs, uPA), neurodegenerative diseases (calpains, caspases, BACE1), pancreatitis (premature trypsin activation).
• Deficient protease activity: Lysosomal storage diseases, coagulation disorders (hemophilia), digestive insufficiency.
• Pathogen proteases as targets: HIV protease inhibitors (PIs), HCV NS3/4A protease inhibitors, SARS-CoV-2 main protease (Mpro) inhibitors (nirmatrelvir).
• Therapeutic protease inhibitors: α1-antitrypsin augmentation (emphysema), MMP inhibitors (cancer—limited success), serine protease inhibitors (anticoagulants, pancreatitis), proteasome inhibitors (bortezomib, carfilzomib—multiple myeloma).

Proteases are master regulators of biology; their dysregulation underlies major diseases, making them premier drug targets.